Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 10Breast Neoplasms 10Melanoma 9Congenital Abnormalities 9Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 6Lymphoma, Follicular 6Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Neuroblastoma 4Neoplasms, Plasma Cell 4Myeloproliferative Disorders 4Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Head and Neck Neoplasms 4Carcinoma, Ovarian Epithelial 4Squamous Cell Carcinoma of Head and Neck 3Primary Myelofibrosis 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Pancreatic Neoplasms 3

Interventions

Carboplatin 41Paclitaxel 40pembrolizumab 38Cyclophosphamide 23Gemcitabine 22130-nm albumin-bound paclitaxel 21Doxorubicin 18Cisplatin 18Albumin-Bound Paclitaxel 18atezolizumab 16Taxes 15Capecitabine 13veliparib 10Nivolumab 9Docetaxel 9Bevacizumab 9olaparib 8liposomal doxorubicin 7Everolimus 7spartalizumab 6durvalumab 6Epirubicin 6trametinib 5pegfilgrastim 5eribulin 5Irinotecan 5Filgrastim 5iniparib 4binimetinib 4apatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Triple Negative Breast Neoplasms × Immunologic Techniques × Clear all
NCT00640861 2018-10-31

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
45 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡